Why the study?
Does antihypertensive therapy or a low-protein diet prevent microvascular damage in diabetic patients and animals?
Does antihypertensive therapy or a low-protein diet prevent microvascular damage in diabetic patients and animals?
Hemodynamic adaptation leading to capillary hypertension is a key driver of diabetic microvascular disease, which can be mitigated by ACE inhibitors or dietary protein restriction in animal models.
Answers are grounded in this paper and cite their sources.
Animal data implicate capillary hypertension in diabetic microangiopathy; leaves open whether ACE inhibitors or protein restriction prevent complications in patients.
Capillary hypertension is suggested to be the underlying cause of microvascular disease affecting the kidney, the retina, and other organs and tissues in diabetic patients and animals. Hyperglycemia causes an expansion of extracellular volume, which induces a vasodilatory response. Hemodynamic adaptation to vasodilation leads to an increase in intracapillary hydraulic pressure, which subsequently causes vascular damage. In experimental animals, restoration of capillary pressure to normal levels by ingestion of a low-protein diet or administration of an angiotensin I-converting enzyme inhibitor has been shown to prevent microvascular damage in the kidney, and dietary protein restriction limits injury in the retina as well. Atrial natriuretic peptide, which is secreted by atrial myocytes in response to volume expansion, may be involved in mediation of the hemodynamic adaptation (vasodilatory response) that results in diabetic microvascular disease.
No takes yet. Share an insight, caveat, or question.
Anderson et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: